GD2 car t manufacturing MOD 003 - primary program manager change
Ended Awarded Last action
- Contract number
- 75N91019F00136
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,696,754
Award facts
- Opportunity
-
- N02CO7240681 Solicitation number
- Contract value 100% obligated
- $4,696,754.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $4,696,754 |
About this award
This is a $4,696,754.00 cost-plus-fixed-fee delivery order awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for GD2 CAR T MANUFACTURING services, with a period of performance through September 29, 2024.
As a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, Leidos Biomedical Research provides comprehensive biomedical research and facilities support services, including manufacturing of therapeutics and vaccines. This contract falls under the company's single-award $6.6 billion Indefinite Delivery Contract with the NCI, which enables the delivery of a wide range of services through individual task orders. The work is primarily performed at Leidos facilities in Fort Detrick and Frederick, Maryland. This contract award did not utilize a set-aside.
Quick answers
Who was awarded contract 75N91019F00136?
75N91019F00136 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2019.
How much is contract 75N91019F00136 worth?
The government has obligated $4,696,754 on 75N91019F00136.
Is contract 75N91019F00136 an order under another contract?
Yes. 75N91019F00136 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91019F00136 competed?
The extent of competition for 75N91019F00136 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award